10-K Filing

AIM IMMUNOTECH INC. CIK: 946644 FY 2018

Filing Information

Form Type	10-K
Accession Number	`0001493152-19-004583`
Period End Date	20181231
Filing Date	20190401
Fiscal Year	2018
Fiscal Period	FY
XBRL Instance	heb-20181231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 72 Income Statement 38 Cash Flow Statement 70 Stockholders Equity 23

Balance Sheet 72 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.41M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$299.00K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.41M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Marketable securities- unrestricted	`AvailableForSaleSecuritiesCurrent`	$695.00K	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Marketable securities- unrestricted	`AvailableForSaleSecuritiesCurrent`	$1.53M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Funds receivable from sale of New Jersey net operating loss	`AccountsReceivableRelatedPartiesCurrent`	$859.00K	USD	Point-in-time
Funds receivable from sale of New Jersey net operating loss	`AccountsReceivableRelatedPartiesCurrent`	-	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	350.00M	shares	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$24.00K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	350.00M	shares	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$235.00K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	48.73M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	32.88M	shares	Point-in-time
Assets held for sale	`AssetsHeldForSaleNotPartOfDisposalGroupCurrent`	-	USD	Point-in-time
Assets held for sale	`AssetsHeldForSaleNotPartOfDisposalGroupCurrent`	$764.00K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	32.88M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$880.00K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$610.00K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	48.73M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$3.50M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$3.80M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$8.59M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$7.78M	USD	Point-in-time
Patent and trademark rights, net	`FiniteLivedIntangibleAssetsNet`	$912.00K	USD	Point-in-time
Patent and trademark rights, net	`FiniteLivedIntangibleAssetsNet`	$858.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.26M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.35M	USD	Point-in-time
Total assets	`Assets`	$13.85M	USD	Point-in-time
Total assets	`Assets`	$14.21M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$741.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$680.00K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$1.00M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$1.97M	USD	Point-in-time
Convertible note payable	`ConvertibleNotesPayableCurrent`	-	USD	Point-in-time
Convertible note payable	`ConvertibleNotesPayableCurrent`	$3.41M	USD	Point-in-time
Current portion of financing obligation	`LongTermDebtCurrent`	-	USD	Point-in-time
Current portion of financing obligation	`LongTermDebtCurrent`	$199.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$5.29M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.71M	USD	Point-in-time
Note payable	`LongTermNotesPayable`	$1.83M	USD	Point-in-time
Note payable	`LongTermNotesPayable`	-	USD	Point-in-time
Financing obligation arising from sale leaseback transaction (Note 19)	`LongTermDebtNoncurrent`	-	USD	Point-in-time
Financing obligation arising from sale leaseback transaction (Note 19)	`LongTermDebtNoncurrent`	$2.32M	USD	Point-in-time
Redeemable warrants	`RedeemableWarrants`	$1.06M	USD	Point-in-time
Redeemable warrants	`RedeemableWarrants`	$962.00K	USD	Point-in-time
Commitments and contingencies (Notes 9,11,12,14, 15 and 19)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Notes 9,11,12,14, 15 and 19)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, par value $0.01 per share, authorized 5,000,000; issued and outstanding; none	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, par value $0.01 per share, authorized 5,000,000; issued and outstanding; none	`PreferredStockValue`	-	USD	Point-in-time
Common stock, par value $0.001 per share, authorized 350,000,000 shares; issued and outstanding 48,734,712 and 32,884,786, respectively	`CommonStockValue`	$33.00K	USD	Point-in-time
Common stock, par value $0.001 per share, authorized 350,000,000 shares; issued and outstanding 48,734,712 and 32,884,786, respectively	`CommonStockValue`	$49.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$323.70M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$317.42M	USD	Point-in-time
Other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$11.00K	USD	Point-in-time
Other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-3.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-308.76M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-318.57M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$15.50M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$8.70M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$5.17M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$13.85M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$14.21M	USD	Point-in-time

Income Statement 38 line items

Line Item	Tag	Value	Unit	Period
Total Revenues	`Revenues`	$367.00K	USD	Annual
Total Revenues	`Revenues`	$437.00K	USD	Annual
Production costs	`ManufacturingCosts`	$1.18M	USD	Annual
Production costs	`ManufacturingCosts`	$884.00K	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$4.10M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$4.78M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$6.57M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$6.20M	USD	Annual
Total Costs and Expenses	`CostsAndExpenses`	$11.85M	USD	Annual
Total Costs and Expenses	`CostsAndExpenses`	$11.86M	USD	Annual
Operating loss	`OperatingIncomeLoss`	$-11.42M	USD	Annual
Operating loss	`OperatingIncomeLoss`	$-11.50M	USD	Annual
Interest and other income (expense)	`InterestAndOtherNonOperatingIncomeExpense`	$46.00K	USD	Annual
Interest and other income (expense)	`InterestAndOtherNonOperatingIncomeExpense`	$88.00K	USD	Annual
Interest expense and finance costs	`InterestAndDebtExpense`	$139.00K	USD	Annual
Interest expense and finance costs	`InterestAndDebtExpense`	$502.00K	USD	Annual
Settlement of litigation	`LitigationSettlementExpense`	$-474.00K	USD	Annual
Settlement of litigation	`LitigationSettlementExpense`	-	USD	Annual
Fair value of convertible note adjustment	`FairValueOfConvertibleNoteAdjustment`	-	USD	Annual
Fair value of convertible note adjustment	`FairValueOfConvertibleNoteAdjustment`	$582.00K	USD	Annual
Redeemable warrants valuation adjustment	`FairValueAdjustmentOfWarrants`	$-1.17M	USD	Annual
Redeemable warrants valuation adjustment	`FairValueAdjustmentOfWarrants`	$-2.42M	USD	Annual
Gain from sale of income tax operating losses	`GainFromSaleOfIncomeTaxOperatingLosses`	$-791.00K	USD	Annual
Gain from sale of income tax operating losses	`GainFromSaleOfIncomeTaxOperatingLosses`	$-859.00K	USD	Annual
Gain on sale of building	`GainLossOnDispositionOfAssets1`	-	USD	Annual
Gain on sale of building	`GainLossOnDispositionOfAssets1`	$223.00K	USD	Annual
Net loss	`NetIncomeLoss`	$-8.26M	USD	Annual
Net loss	`NetIncomeLoss`	$-9.81M	USD	Annual
Unrealized gain (loss) on securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$33.00K	USD	Annual
Unrealized gain (loss) on securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-23.00K	USD	Annual
Reclassification adjustments for realized gain (loss) on sales of short-term marketable securities and for impairment losses on investments included in net loss	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-17.00K	USD	Annual
Reclassification adjustments for realized gain (loss) on sales of short-term marketable securities and for impairment losses on investments included in net loss	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$9.00K	USD	Annual
Net comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-8.24M	USD	Annual
Net comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-9.83M	USD	Annual
Basic and diluted loss per share	`EarningsPerShareBasicAndDiluted`	$-0.22	USD	Annual
Basic and diluted loss per share	`EarningsPerShareBasicAndDiluted`	$-0.29	USD	Annual
Weighted average shares outstanding basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	28.68M	shares	Annual
Weighted average shares outstanding basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	44.19M	shares	Annual

Cash Flow Statement 70 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-8.26M	USD	Annual
Net loss	`NetIncomeLoss`	$-9.81M	USD	Annual
Depreciation of property and equipment	`Depreciation`	$856.00K	USD	Annual
Depreciation of property and equipment	`Depreciation`	$948.00K	USD	Annual
Fair value of convertible note adjustment	`FairValueOfConvertibleNoteAdjustment`	-	USD	Annual
Fair value of convertible note adjustment	`FairValueOfConvertibleNoteAdjustment`	$582.00K	USD	Annual
Amortization of debt issue costs	`AmortizationOfFinancingCosts`	$37.00K	USD	Annual
Amortization of debt issue costs	`AmortizationOfFinancingCosts`	$263.00K	USD	Annual
Amortization and abandonment of patent and trademark rights	`AmortizationAndAbandonmentOfIntagibleAssets`	$63.00K	USD	Annual
Amortization and abandonment of patent and trademark rights	`AmortizationAndAbandonmentOfIntagibleAssets`	$22.00K	USD	Annual
Redeemable warrants valuation adjustment	`FairValueAdjustmentOfWarrants`	$-1.17M	USD	Annual
Redeemable warrants valuation adjustment	`FairValueAdjustmentOfWarrants`	$-2.42M	USD	Annual
Equity-based compensation	`ShareBasedCompensation`	$571.00K	USD	Annual
Equity-based compensation	`ShareBasedCompensation`	$929.00K	USD	Annual
Realized gain (loss) on securities	`MarketableSecuritiesRealizedGainLoss`	$17.00K	USD	Annual
Realized gain (loss) on securities	`MarketableSecuritiesRealizedGainLoss`	$14.00K	USD	Annual
Gain on sale of building	`GainLossOnDispositionOfAssets1`	-	USD	Annual
Gain on sale of building	`GainLossOnDispositionOfAssets1`	$223.00K	USD	Annual
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$251.00K	USD	Annual
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$13.00K	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$1.07M	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$24.00K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$566.00K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$166.00K	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-922.00K	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$604.00K	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-10.64M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-7.94M	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$51.00K	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$20.00K	USD	Annual
Additions to patent and trademark rights	`PaymentsToAcquireIntangibleAssets`	$76.00K	USD	Annual
Additions to patent and trademark rights	`PaymentsToAcquireIntangibleAssets`	$49.00K	USD	Annual
Proceeds from sale of building	`ProceedsFromSaleOfBuildings`	$1.05M	USD	Annual
Proceeds from sale of building	`ProceedsFromSaleOfBuildings`	-	USD	Annual
Sales and maturities of short-term marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$2.80M	USD	Annual
Sales and maturities of short-term marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$-831.00K	USD	Annual
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$2.73M	USD	Annual
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$92.00K	USD	Annual
Proceeds from sale of common stock, net of issuance costs	`ProceedsFromIssuanceOfCommonStock`	$2.42M	USD	Annual
Proceeds from sale of common stock, net of issuance costs	`ProceedsFromIssuanceOfCommonStock`	$5.07M	USD	Annual
Proceeds for lease financing obligation	`SaleLeasebackTransactionGrossProceedsFinancingActivities`	-	USD	Annual
Proceeds for lease financing obligation	`SaleLeasebackTransactionGrossProceedsFinancingActivities`	$4.08M	USD	Annual
Financing obligation payment	`RepaymentsOfLongTermDebt`	$264.00K	USD	Annual
Financing obligation payment	`RepaymentsOfLongTermDebt`	-	USD	Annual
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$102.00K	USD	Annual
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$439.00K	USD	Annual
Proceeds from note payable	`ProceedsFromNotesPayable`	$1.90M	USD	Annual
Proceeds from note payable	`ProceedsFromNotesPayable`	$3.06M	USD	Annual
Payoff of mortgage note payable	`ProceedsFromRepaymentsOfNotesPayable`	$-1.96M	USD	Annual
Payoff of mortgage note payable	`ProceedsFromRepaymentsOfNotesPayable`	-	USD	Annual
Security deposits paid	`SecurityDepositPaid`	$114.00K	USD	Annual
Security deposits paid	`SecurityDepositPaid`	-	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$4.21M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$9.44M	USD	Annual
Net decrease in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-996.00K	USD	Annual
Net decrease in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-1.11M	USD	Annual
Cash and cash equivalents at beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$1.41M	USD	Point-in-time
Cash and cash equivalents at beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$299.00K	USD	Point-in-time
Cash and cash equivalents at beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$2.41M	USD	Point-in-time
Cash and cash equivalents at end of year	`CashAndCashEquivalentsAtCarryingValue`	$1.41M	USD	Point-in-time
Cash and cash equivalents at end of year	`CashAndCashEquivalentsAtCarryingValue`	$299.00K	USD	Point-in-time
Cash and cash equivalents at end of year	`CashAndCashEquivalentsAtCarryingValue`	$2.41M	USD	Point-in-time
Issuance of common stock for accounts payable and accrued expenses	`StockIssued1`	$898.00K	USD	Annual
Issuance of common stock for accounts payable and accrued expenses	`StockIssued1`	$330.00K	USD	Annual
Unrealized (loss) gain on marketable securities	`UnrealizedGainLossOnSecurities`	$16.00K	USD	Annual
Unrealized (loss) gain on marketable securities	`UnrealizedGainLossOnSecurities`	$-14.00K	USD	Annual
Fair value of redeemable warrants granted	`FairValueOfRedeemableWarrants`	$2.05M	USD	Annual
Fair value of redeemable warrants granted	`FairValueOfRedeemableWarrants`	$1.26M	USD	Annual
Cash paid for interest expense	`InterestPaidNet`	$328.00K	USD	Annual
Cash paid for interest expense	`InterestPaidNet`	$101.00K	USD	Annual

Stockholders Equity 23 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$15.50M	USD	Point-in-time
Balance	`StockholdersEquity`	$8.70M	USD	Point-in-time
Balance	`StockholdersEquity`	$5.17M	USD	Point-in-time
Shares sold at the market	`SaleOfStockConsiderationReceivedOnTransaction`	$1.25M	USD	Point-in-time
Shares sold at the market	`SaleOfStockConsiderationReceivedOnTransaction`	$803.00K	USD	Annual
Shares sold at the market	`SaleOfStockConsiderationReceivedOnTransaction`	$237.00K	USD	Annual
Common stock issuance, net of costs	`StockIssuedDuringPeriodValueNewIssues`	$2.78M	USD	Annual
Common stock issuance, net of costs	`StockIssuedDuringPeriodValueNewIssues`	$2.18M	USD	Annual
Convertible note origination shares	`DebtConversionConvertedInstrumentAmount1`	$84.00K	USD	Annual
Other issuance	`StockIssuedDuringPeriodValueOther`	$898.00K	USD	Annual
Other issuance	`StockIssuedDuringPeriodValueOther`	$330.00K	USD	Annual
Other issuance, shares	`StockIssuedDuringPeriodSharesOther`	500,000.00	shares	Annual
Equity-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$571.00K	USD	Annual
Equity-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$929.00K	USD	Annual
Redeemable warrants	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$2.05M	USD	Annual
Redeemable warrants	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$221.00K	USD	Annual
Warrants issued for building sales leaseback	`AdjustmentsToAdditionalPaidInCapitalWarrantsIssuedForBuildingSalesLeaseback`	$1.15M	USD	Annual
Deemed dividends	`Dividends`	$388.00K	USD	Annual
Net comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-8.24M	USD	Annual
Net comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-9.83M	USD	Annual
Balance	`StockholdersEquity`	$15.50M	USD	Point-in-time
Balance	`StockholdersEquity`	$8.70M	USD	Point-in-time
Balance	`StockholdersEquity`	$5.17M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.